ARCHIVES

HHS Hearings to Form National Breast Cancer Strategy. Shalala Says

This article is from The Cancer Letter archive.

Vol. 19 No. 42 | October 29, 1993

Download PDF Visit The Full Archive

Related Articles

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005

Interview: “People don’t understand Clinical Trials.

September 5, 1997

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

March 20, 1992